top of page
Senior Couple


The Next Frontier in Heart Failure Treatment

About Us
Cardiac Success is developing the V-sling device to improve the lives of the millions of patients who, despite guidance-directed medical therapy, continue to suffer and deteriorate from Heart Failure with Reduced Ejection Fraction (HFrEF). The V-sling is a transcatheter ventricular repair device designed based on a successful surgical papillary muscle approximation procedure.
V-Sling_Image_02 copy.jpg


Ventricular Repair Device Treating
Heart Failure with Left Ventricle Dilation

Heart Failure​

There are currently about 8 million heart failure patients worldwide whose lives could potentially be improved by treatment with the V-sling device. Cardiac Success aims to treat patients suffering from HFrEF (Heart Failure with reduced Ejection Fraction), a condition typically associated with ventricular dilation, papillary muscle dislocation, and low ejection fraction.

Anchor 1
Our Technology 


The V-sling is a transcatheter ventricular repair device designed based on a successful surgical papillary muscle approximation procedure.

V-Sling Unique Benefits

  • Restores the conical shape of the Left Ventricle

  • Eliminates leaflet tethering

  • Adjustable implant size for optimized Left Ventricle repair

  • Safe anchorless implant, no endocardium penetration

  • Does not block future interventions

Anchor 2
Anchor 3


Israeli Medical Device Startup, Cardiac Success Ltd.,
Closes US $5.2M Series A Financing.

The round was led by 415 CAPITAL, a specialist medical technology venture capital firm who was joined by an unnamed strategic investor and global leader in structural heart interventions. Proceeds will be used for pre-clinical testing and the completion of a First-in-Human trial of the company’s innovative “V-sling” heart failure therapy.

Cardiac Success Awarded €10M in Grants and Equity Investment from the European Innovation Council

Funds to accelerate the clinical development of the novel “V-sling” system, a transcatheter ventricular repair implant designed to provide a new therapy for heart failure patients.

Anchor 4
Our Team

Boaz Manash,

Experienced R&D leader in start-ups and at large medical device companies.  Previously leader of the promising Mitral program in Edwards Lifesciences, the Sapien M3


David Neustadter, PhD

  CTO & Founder

Over 20 years experience in medical device design. Co-founder, CTO and VP R&D in 2 previous medical device startup companies.


Dr. Shimon Eckhouse

 Chairman & Co-Founder

An inventor, active entrepreneur and investor in MedTech companies. Former chairman and co-founder of Syneron Medical (acquired by APAX), founder, chairman and CEO of Lumenis and co-founder of Ventor (acquired by Medtronic).


Lea Waisman Shaler,

15 years of experience in design, development, and management of R&D projects in interventional cardiology and gastroenterology.

פרופ ביאר.jpg

Prof. Rafael Beyar


Interventional cardiologist, an established entrepreneur, former director and CEO of Rambam Medical Center. Successfully founded and sold 2 major cardiovascular companies.

This project has received funding from the European Union’s Horizon Europe under grant agreement

No. 190122502

bottom of page